Concepedia

Johannes C. Nunnink

JC

Statistics

Publications

6

Citations

3.3K

H-Index

6

Active since

1978

Affiliations

University of Vermont(Current)

National Cancer Institute

Johannes C. Nunnink is an author at University of Vermont specializing in molecular biology, cancer therapeutics, and biosynthesis.

Top concepts

Publications per year

1978–2019

6

Publications

6

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

, , +7

Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia

Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan et al. · Clinical Cancer Research · 2008 · 129 citations

Multicentric reticulohistiocytosis and cancer: A case report and review of the literature

Johannes C. Nunnink, Paul A. Krusinski, Jerome W. Yates · Medical and Pediatric Oncology · 1985 · 87 citations

The ontogeny of nuclear aryl hydrocarbon hydroxylase

Johannes C. Nunnink, Augustine Chuang, Edward Bresnick · Chemico-Biological Interactions · 1978 · 21 citations

, , +2

Oncology Care in Rural Northern New England

Alison Johnson, Judy R. Rees, Molly Schwenn et al. · Journal of Oncology Practice · 2010 · 19 citations · Full text

1–5 of 6